Rockefeller philanthropy and modern biomedicine

Rockefeller philanthropy and modern biomedicine

by Schneider

Part of Philanthropic and nonprofit studies

About
"The eight case studies in this edited volume show in detail how the Rockefeller Foundation's gifts affected medical research, education, and public health in Europe, the Soviet Union, and China between World War I and the Cold War. The cases reveal the varied success of the country-level programs in meeting the Foundation's goals. Despite the Foundation's primary emphasis on strengthening established medical programs, major medical advances were achieved in several places without a notable history of medical research. In other circumstances, however, the Rockefeller Foundation was confronted with local cultural and political imperatives that reshaped or weakened its objectives. The book offers important lessons regarding the situations in which international philanthropy is likely to be most effective."--BOOK JACKET.

Discuss Rockefeller philanthropy and modern biomedicine with other readers

Join or start a book club for Rockefeller philanthropy and modern biomedicine on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.

Frequently asked questions

How do I join a book club for Rockefeller philanthropy and modern biomedicine?

Sign up free on Readfeed, then browse public clubs or start your own club with Rockefeller philanthropy and modern biomedicine as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.

Can I discuss Rockefeller philanthropy and modern biomedicine with other readers online?

Yes. Readfeed book clubs let you chat live, share progress, and join discussions about Rockefeller philanthropy and modern biomedicine with readers worldwide — whether your club is virtual, in-person, or hybrid.

Is Readfeed free?

Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.